Not applicableNot Yet RecruitingNCT07546357What this trial is testingAIManage Using an AI-driven CDS and ChatbotWho this might be right forDiabetesObesityMedication Side Effects NYU Langone Health 16
Early research (Phase 1)Study completedNCT00365781What this trial is testingExamination of Dermatologic Effects From Subcutaneous Injections of ISIS 113715Who this might be right forType 2 Diabetes Mellitus Ionis Pharmaceuticals, Inc. 10
Not applicableLooking for participantsNCT04154553What this trial is testingPharmacogenetic Testing of Patients With Unwanted Adverse Drug Reactions or Therapy FailureWho this might be right forAdverse Drug ReactionTherapy Failure University Hospital, Basel, Switzerland 400
Very early researchStudy completedNCT03420469What this trial is testingBupropion Stereoselective Disposition and CYP2D6-mediated Drug Interactions in Healthy VolunteersWho this might be right forAdverse Effect of Drug Therapy Metabolism Medications (Diagnosis) Indiana University 28
Not applicableNot Yet RecruitingNCT07668765What this trial is testingGLP-1 Receptor Agonists and Early Proctologic Effects in Morbid ObesityWho this might be right forMorbid ObesityAnorectal DiseasesDrug-Related Side Effects and Adverse Reactions+2 more Gazi University 100
Not applicableLooking for participantsNCT07183579What this trial is testingEffective Dosing of Burosumab in XLHWho this might be right forX-linked Hypophosphatemia (XLH) University of Nottingham 120
Not applicableLooking for participantsNCT05951660What this trial is testingSex, Psychopharmacology, and DiabetesWho this might be right forSchizophreniaSchizophrenia Spectrum and Other Psychotic DisordersDiabetes Mellitus+4 more Zealand University Hospital 256
Not applicableStudy completedNCT02428660What this trial is testingDrug & Gene Interaction Risk Analysis With & Without Genetic Testing Among Patients Undergoing MTMWho this might be right forCytochrome P450 CYP2D6 Enzyme DeficiencyPoor Metabolizer Due to Cytochrome P450 CYP2D6 VariantUltrarapid Metabolizer Due to Cytochrome P450 CYP2D6 Variant+6 more Genelex Corporation 341
Post-approval studies (Phase 4)Study completedNCT00224068What this trial is testingEffect of Iron Therapy as an Adjunct to Epoetin Alfa in the Anemia of Cancer ChemotherapyWho this might be right forAnemia Watson Pharmaceuticals 180
Early research (Phase 1)UnknownNCT00004036What this trial is testingCombination Chemotherapy Plus Amifostine in Treating Patients With Advanced CancerWho this might be right forChronic Myeloproliferative DisordersDrug/Agent Toxicity by Tissue/OrganLeukemia+5 more The Cleveland Clinic 30
Not applicableStudy completedNCT02191358What this trial is testingYouScript IMPACT RegistryWho this might be right forAdverse Drug EventsAdverse Drug ReactionsDrug Interaction Potentiation+10 more Genelex Corporation 800
Post-approval studies (Phase 4)Study completedNCT00224042What this trial is testingEffect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients Receiving Erythropoietic AgentsWho this might be right forAnemia, Iron-DeficiencyKidney Failure, Chronic Watson Pharmaceuticals 52
Post-approval studies (Phase 4)Ended earlyNCT02638129What this trial is testingNaltrexone/Bupropion Cardiovascular Outcomes StudyWho this might be right forObesityCardiovascular Diseases Orexigen Therapeutics, Inc 67
Not applicableUnknownNCT00437775What this trial is testingACEIs and ARBs Treatment in Diabetic Patients -Drug Interactions and Adverse Drug EffectsWho this might be right forDiabetes Mellitus Type 2 Assaf-Harofeh Medical Center 300